NCT06853899

Brief Summary

This clinical trial evaluates the efficacy of three skincare products-Truology A2 (0.2% Retinaldehyde Serum), Truology C-Boost, and Truology Barrier Restore-in improving skin quality and health. The study will assess improvements in skin firmness, evenness, brightness, hydration, fine lines/wrinkles, redness, and skin stress/irritation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 21, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 25, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 3, 2025

Completed
Last Updated

March 3, 2025

Status Verified

February 1, 2025

Enrollment Period

3 months

First QC Date

February 25, 2025

Last Update Submit

February 25, 2025

Conditions

Keywords

Skin QualityFacial Skin Health

Outcome Measures

Primary Outcomes (1)

  • Improvement in self-reported skin health symptoms (measured via questionnaires)

    Baseline, Day 1, Week 2, Week 4, Week 6

Secondary Outcomes (1)

  • Changes in overall facial skin quality and health (measured via expert skin grading)

    Baseline and Week 6

Study Arms (1)

Truology Skincare Routine

EXPERIMENTAL

A single-arm study in which all participants will use the Truology Skincare Routine for 6 weeks.

Dietary Supplement: Truology A2Dietary Supplement: Truology C-BoostDietary Supplement: Truology Barrier Restore

Interventions

Truology A2DIETARY_SUPPLEMENT

Truology A2 (0.2% Retinaldehyde Serum) - Applied once daily at night after cleansing.

Truology Skincare Routine
Truology C-BoostDIETARY_SUPPLEMENT

Truology C-Boost - Applied twice daily (morning \& night).

Truology Skincare Routine
Truology Barrier RestoreDIETARY_SUPPLEMENT

Applied twice daily (morning \& night) as the final skincare step.

Truology Skincare Routine

Eligibility Criteria

Age35 Years - 55 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Be female-at-birth
  • Be aged 35-55
  • Anyone currently experiencing issues with skin health, including: Poor skin texture, Skin discoloration, Appearance of fine lines and wrinkles Dull skin, Poor skin firmness, Dry skin, Skin redness, Irritated and stressed skin
  • Willing to use the test products as follows: Truology A2 - Once a day at night. Use 1 pump for the whole face. Use first after cleansing the skin on dry skin. C-Boost - Twice a day (AM \& PM). In the morning, first use one pump for the full face after cleansing the skin. At night, use the A2 first, then C-Boost. Barrier Restore - Twice a day (AM \& PM). Use one pump for the full face. Use it after C-Boost for the final step in the skincare routine, and complete questionnaires and take photos
  • Have been using the same skincare routine for at least one month prior to the study, i.e., cleanser, toner, and make-up remover
  • Willing to maintain the same skincare routine and products throughout the 6-week trial, e.g., moisturizer, cleanser, or SPF
  • Have been consistently taking medications, oral supplements, or herbal remedies targeted at skin health and appearance for at least 3 months prior to the study and willing to maintain this routine for the duration of the study
  • Agree to avoid using any other products or new forms of regular medication or supplements that target skin health and appearance
  • Anyone who is generally healthy - does not live with any uncontrolled chronic disease
  • Anyone who is currently using or has used the past, exfoliating acids (AHAs/BHA) or retinoids in (i.e., salicylic acid, glycolic acid, mandelic acid, or lactic acid).
  • Anyone willing to stop using exfoliating acids or retinoids for the duration of the study
  • Anyone in good general health
  • Anyone who resides in the United States

You may not qualify if:

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
  • Anyone currently using a prescription skin treatment
  • Anyone with known severe allergic reactions
  • Anyone unwilling to avoid excessive sun exposure
  • Any women who are pregnant, breastfeeding, or attempting to conceive
  • Anyone unwilling to follow the study protocol
  • Anyone who identifies as having sensitive skin
  • Anyone who has undergone any facial surgeries or invasive skin treatments in the last 6 months
  • Anyone who is planning to undergo any facial treatments during the study period, including botox, dermal filler, or chemical peels
  • Anyone who has not stopped using hormonal birth control within the past month
  • Anyone with any chronic skin conditions on the face (e.g., eczema or psoriasis)
  • Anyone with a history of skin cancer or pre-cancerous skin lesions on the face
  • Anyone currently testing, or plans to in the next 6 weeks, a product for another research study
  • Anyone with a history of substance abuse
  • Anyone who is currently, or has been for the past 3 months, a smoker
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Citruslabs

Las Vegas, Nevada, 89118, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2025

First Posted

March 3, 2025

Study Start

October 21, 2024

Primary Completion

January 10, 2025

Study Completion

January 10, 2025

Last Updated

March 3, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations